Dipankar Bhattacharjee to lead Teva’s global generics group
Dipankar Bhattacharjee has been appointed as the President and Chief utive of Teva Pharmaceutical Industries’ Global Generic Medicines Group, replacing […]
Dr. Reddys to acquire 8 ANDAs for $350 million – Aims to become relevant in the US
Dr. Reddys Laboratories has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd and an affiliate of Allergan plc […]
Gujarat Attracts Global Healthcare Brands
Gujarat perhaps going to be the next hub of Indian healthcare enterprise. After Vicks and Colgate Palmolive, US-based Abbott Laboratories […]
